NCT05908292

Brief Summary

The goal of this Pilot Randomized Control Trial (RCT) is to determine if a larger RCT evaluating the effect of self-scar tissue massage of episiotomy and/or vagina/perineal tear scar tissue on pelvic health outcomes is feasible. The main questions it aims to answer are: Can the investigators recruit 130 participants and aim for 80% retention of participants in this study? Are the response rates to questionnaires and completeness of questionnaires acceptable? Do the participants find the self-scar tissue massage intervention easy and acceptable to perform and do they adhere to the protocol? Type of Study: Clinical Trial Participant Population/Health Conditions: The participant population will be 18 years of age or older, primiparous, within 1 year postpartum after vaginal delivery with healed episiotomy and/or vaginal perineal tear(s) as confirmed to them by their maternity care provider or family doctor at their 6 week postpartum check or other appointment. The participants will also need to have sufficient proficiency in English to understand intervention instructional video and complete written questionnaires. Investigators will compare the scores on two reliable and validated pelvic health questionnaires in those in the intervention and control groups. The intervention group will be provided an instructional video on self-scar tissue massage and asked to perform self-scar massage and record their intervention and experience over a 6-week period. The control group will receive routine postnatal care (no self-scar massage training or performance). Patient medical records will be used to collect demographic data and labour and delivery characteristics. Two reliable and validated pelvic health questionnaires will be used for outcome measures. Baseline outcomes will be performed at the start of the study and then repeated 6 weeks later and again 18 weeks later.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

September 21, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 9, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

March 30, 2026

Status Verified

December 1, 2024

Enrollment Period

1.3 years

First QC Date

May 15, 2023

Last Update Submit

March 24, 2026

Conditions

Keywords

Perineal TearVaginal TearEpisiotomy

Outcome Measures

Primary Outcomes (5)

  • Rate of Participant Recruitment

    To evaluate the rate of participant recruitment, the investigators will calculate how many participants were recruited on average per month per hospital site.

    1 year

  • Rate of Participant Attrition

    To evaluate the rate of participant attrition, the investigators will calculate the number of participants that drop out of the study over the total number of participants that are randomized in the study over the study period.

    1 year

  • Number of Pelvic Floor Distress Inventory (PFDI-20) Outcome Measures with missing data

    To evaluate the response rate and the completeness of the PFDI-20 the investigators will track how many questionnaires are not completed and determine if there is any missing data in the responses to the PFDI-20.

    1 year

  • Number of The Carol Scale with missing data

    To evaluate the response rate and the completeness of the Carol Scale the investigators will track how many questionnaires are not completed and determine if there is any missing data in the responses to the Carol Scale.

    1 year

  • Number of participants to complete self-scar massage protocol as intended

    To evaluate the acceptability of the self-scar massage intervention, the investigators will examine participants' reported intervention frequency and time of intervention on their records and note any deviation from the intervention protocol. Some participant interviews will be conducted from a program evaluation lens to determine how the intervention was received. Exemplar quotes will be used to describe participants experience of the self-scar massage intervention.

    1 year

Study Arms (2)

Episiotomy and Vaginal/Perineal Tear Self-Scar Massage

EXPERIMENTAL

This Arm will be instructed in and perform self-scar massage to their pelvic floor scar tissue.

Procedure: Pelvic Floor Scar Tissue Self-Scar Massage

Standard Postnatal Care

NO INTERVENTION

This Arm will not be instructed in or perform self-scar massage to their pelvic floor scar tissue.

Interventions

Self scar-massage intervention of healed pelvic floor scar tissue for 5 minutes, 3x/week for 6 weeks.

Episiotomy and Vaginal/Perineal Tear Self-Scar Massage

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Primiparous
  • Within 1 year postpartum after vaginal delivery with episiotomy and/or vaginal/perineal tear
  • Healed episiotomy and/or vagina/perineal tear as confirmed to them by their maternity care provider or family doctor at their postpartum check or other appointment
  • Sufficient proficiency in English to understand intervention instructional video and complete written questionnaires.

You may not qualify if:

  • Self-reported current vaginal infection or urinary tract infection
  • Self-reported gynecological surgery after delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Calgary

Calgary, Alberta, T2N 1N4, Canada

Location

MeSH Terms

Conditions

Cicatrix

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Erin Brennand, MD, MSc

    University of Calgary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2023

First Posted

June 18, 2023

Study Start

September 21, 2023

Primary Completion

January 9, 2025

Study Completion

March 1, 2025

Last Updated

March 30, 2026

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations